rs118017785

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022489.4(INF2):​c.843+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0748 in 1,555,734 control chromosomes in the GnomAD database, including 4,917 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.059 ( 333 hom., cov: 33)
Exomes 𝑓: 0.076 ( 4584 hom. )

Consequence

INF2
NM_022489.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.14

Publications

5 publications found
Variant links:
Genes affected
INF2 (HGNC:23791): (inverted formin 2) This gene represents a member of the formin family of proteins. It is considered a diaphanous formin due to the presence of a diaphanous inhibitory domain located at the N-terminus of the encoded protein. Studies of a similar mouse protein indicate that the protein encoded by this locus may function in polymerization and depolymerization of actin filaments. Mutations at this locus have been associated with focal segmental glomerulosclerosis 5.[provided by RefSeq, Aug 2010]
INF2 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease dominant intermediate E
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
  • focal segmental glomerulosclerosis 5
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 14-104706192-C-T is Benign according to our data. Variant chr14-104706192-C-T is described in ClinVar as Benign. ClinVar VariationId is 261628.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0821 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INF2NM_022489.4 linkc.843+16C>T intron_variant Intron 6 of 22 ENST00000392634.9 NP_071934.3 Q27J81-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INF2ENST00000392634.9 linkc.843+16C>T intron_variant Intron 6 of 22 5 NM_022489.4 ENSP00000376410.4 Q27J81-1

Frequencies

GnomAD3 genomes
AF:
0.0591
AC:
8994
AN:
152160
Hom.:
333
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0197
Gnomad AMI
AF:
0.0691
Gnomad AMR
AF:
0.0604
Gnomad ASJ
AF:
0.109
Gnomad EAS
AF:
0.0102
Gnomad SAS
AF:
0.0795
Gnomad FIN
AF:
0.0466
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.0840
Gnomad OTH
AF:
0.0683
GnomAD2 exomes
AF:
0.0685
AC:
11421
AN:
166610
AF XY:
0.0719
show subpopulations
Gnomad AFR exome
AF:
0.0170
Gnomad AMR exome
AF:
0.0443
Gnomad ASJ exome
AF:
0.100
Gnomad EAS exome
AF:
0.0148
Gnomad FIN exome
AF:
0.0531
Gnomad NFE exome
AF:
0.0862
Gnomad OTH exome
AF:
0.0963
GnomAD4 exome
AF:
0.0765
AC:
107317
AN:
1403456
Hom.:
4584
Cov.:
32
AF XY:
0.0778
AC XY:
53853
AN XY:
692062
show subpopulations
African (AFR)
AF:
0.0156
AC:
502
AN:
32092
American (AMR)
AF:
0.0475
AC:
1743
AN:
36730
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
2578
AN:
25136
East Asian (EAS)
AF:
0.0104
AC:
381
AN:
36486
South Asian (SAS)
AF:
0.0817
AC:
6531
AN:
79926
European-Finnish (FIN)
AF:
0.0513
AC:
2503
AN:
48830
Middle Eastern (MID)
AF:
0.103
AC:
512
AN:
4970
European-Non Finnish (NFE)
AF:
0.0814
AC:
87971
AN:
1081168
Other (OTH)
AF:
0.0791
AC:
4596
AN:
58118
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
5022
10044
15067
20089
25111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3218
6436
9654
12872
16090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0590
AC:
8991
AN:
152278
Hom.:
333
Cov.:
33
AF XY:
0.0573
AC XY:
4270
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0197
AC:
819
AN:
41568
American (AMR)
AF:
0.0602
AC:
922
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.109
AC:
378
AN:
3472
East Asian (EAS)
AF:
0.0101
AC:
52
AN:
5174
South Asian (SAS)
AF:
0.0795
AC:
384
AN:
4828
European-Finnish (FIN)
AF:
0.0466
AC:
495
AN:
10622
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0839
AC:
5706
AN:
67982
Other (OTH)
AF:
0.0699
AC:
148
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
444
888
1331
1775
2219
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0780
Hom.:
86
Bravo
AF:
0.0569
Asia WGS
AF:
0.0520
AC:
182
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 29, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Focal segmental glomerulosclerosis 5;C4302667:Charcot-Marie-Tooth disease dominant intermediate E Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
1.8
DANN
Benign
0.50
PhyloP100
-1.1
RBP_binding_hub_radar
0.67
RBP_regulation_power_radar
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs118017785; hg19: chr14-105172529; API